Connectus Wealth’s Pfizer PFE Stock Holding History

Connectus Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.98M	Sell	71,258 -28,506	-29%	-$791K	0.05%	184
2023 Q4	$2.87M	Sell	99,764 -85,487	-46%	-$2.58M	0.06%	213
2023 Q3	$6.15M	Buy	185,251 +6,422	+4%	+$227K	0.14%	147
2023 Q2	$6.56M	Sell	178,829 -489,225	-73%	-$19M	0.15%	124
2023 Q1	$27.3M	Buy	668,054 +30,820	+5%	+$1.33M	0.67%	47
2022 Q4	$32.7M	Buy	637,234 +9,163	+1%	+$439K	0.77%	36
2022 Q3	$27.5M	Buy	628,071 +29,865	+5%	+$1.45M	0.57%	45
2022 Q2	$31.4M	Buy	598,206 +66,736	+13%	+$3.4M	0.72%	31
2022 Q1	$31.4M	Sell	531,470 -98,143	-16%	-$5.09M	0.99%	26
2021 Q4	$37.2M	Buy	+629,613	New	+$31.2M	1.44%	14

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Connectus Wealth's PFE Position: Q1 2024 in Review

Connectus Wealth reduced its Pfizer (PFE) stake by 29% in Q1 2024, selling an estimated $791K and leaving 71,258 shares worth $1.98M. The position accounts for 0.05% of the portfolio, ranked #184.

Connectus Wealth first reported a position in PFE in Q4 2021 and has held it in 10 quarters since. The position peaked at $37.2M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Connectus Wealth held 71,258 shares of Pfizer worth $1.98M as of Q1 2024.
Connectus Wealth sold 28,506 Pfizer shares in Q1 2024, an estimated $791K.
Pfizer made up 0.05% of Connectus Wealth's portfolio in Q1 2024, its #184 holding.
Connectus Wealth first reported a position in Pfizer in Q4 2021 and has held it in 10 quarters since.
Connectus Wealth's Pfizer position peaked at $37.2M in Q4 2021.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.